Comparison of Ibuprofen, Cyclobenzaprine, or Both for Acute Cervical Strain: A Randomized Clinical Trial
This study has been completed.
Sponsor:
Stony Brook University
Information provided by:
Stony Brook University
ClinicalTrials.gov Identifier:
NCT00790270
First received: November 12, 2008
Last updated: October 22, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to see whether the combination of a muscle relaxant and anti-inflammatory drug is more effective at relieving pain in patients with neck strains or whiplash than either of the two medications alone.
| Condition | Intervention | Phase |
|---|---|---|
|
Cervical Strain |
Drug: Cyclobenzaprine Drug: Ibuprofen Drug: Ibuprofen plus Cyclobenzaprine |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Comparison of Ibuprofen, Cyclobenzaprine, or Both for Acute Cervical Strain: A Randomized Clinical Trial |
Resource links provided by NLM:
Drug Information available for:
Cyclobenzaprine
Cyclobenzaprine hydrochloride
Ibuprofen
Ibuprofen sodium
Ibuprofen lysinate
U.S. FDA Resources
Further study details as provided by Stony Brook University:
Primary Outcome Measures:
- Pain [ Time Frame: Daily for 1 week ] [ Designated as safety issue: No ]
- Use of Rescue Medications [ Time Frame: 24 hours ] [ Designated as safety issue: No ]the number of patients taking additional rescue medications beyond the study meds
Secondary Outcome Measures:
- Time to Resumption of Work [ Time Frame: 1 week ] [ Designated as safety issue: No ]
- Resumption of Work or School [ Time Frame: next day ] [ Designated as safety issue: No ]number of patients resuming regular activity the day following enrollment.
| Enrollment: | 61 |
| Study Start Date: | January 2003 |
| Study Completion Date: | January 2004 |
| Primary Completion Date: | January 2004 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Active Comparator: Cyclobenzaprine |
Drug: Cyclobenzaprine
5 mg orally every 8 hours as needed
Other Name: flexeril
|
| Active Comparator: Ibuprofen |
Drug: Ibuprofen
Ibuprofen 400 mg every 8 hours as needed
Other Name: motrin, advil
|
| Experimental: Ibuprophen plus Cyclobenzaprine |
Drug: Ibuprofen plus Cyclobenzaprine
Ibuprofen 400 mg plus cyclobenzaprine 5 mg every 8 hours as needed
Other Name: motrin or advil with flexeril
|
Detailed Description:
Muscle relaxants have been used extensively for neck and back pain since muscle spasm is thought to play a role in the cycle of pain and spasm. However, prior studies have conflicting results regarding their additive effect when given in addition to analgesics such as the NSAIDs. Because they have the potential to lead to adverse events their efficacy should be clearly demonstrated before their routine use.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- neck pain within 24 hours of injury
Exclusion Criteria:
- Children, allergy or contraindication to any of the study drugs
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00790270
Locations
| United States, New York | |
| Stony Brook University | |
| Stony Brook, New York, United States, 11733 | |
Sponsors and Collaborators
Stony Brook University
Investigators
| Principal Investigator: | adam singer, md | Stony Brook University |
More Information
No publications provided
| Responsible Party: | Adam Singer, MD, Stony Brook University |
| ClinicalTrials.gov Identifier: | NCT00790270 History of Changes |
| Other Study ID Numbers: | SB2003-1234 |
| Study First Received: | November 12, 2008 |
| Results First Received: | October 19, 2009 |
| Last Updated: | October 22, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Stony Brook University:
|
Cervical strain whiplash ibuprofen cyclobenzaprine |
Additional relevant MeSH terms:
|
Sprains and Strains Wounds and Injuries Ibuprofen Amitriptyline Cyclobenzaprine Anti-Inflammatory Agents, Non-Steroidal Analgesics, Non-Narcotic Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Pharmacologic Actions Anti-Inflammatory Agents Therapeutic Uses Antirheumatic Agents |
Cyclooxygenase Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Central Nervous System Agents Antidepressive Agents, Tricyclic Antidepressive Agents Psychotropic Drugs Muscle Relaxants, Central Neuromuscular Agents Tranquilizing Agents Central Nervous System Depressants Adrenergic Uptake Inhibitors Adrenergic Agents Neurotransmitter Agents Neurotransmitter Uptake Inhibitors |
ClinicalTrials.gov processed this record on May 19, 2013